check_circleStudy Completed
Thromboembolism
Bayer Identifier:
14343
ClinicalTrials.gov Identifier:
EudraCT Number:
Not Available
EU CT Number:
Not Available
SALTO - Epidemiological study on compliance and treatment satisfaction
Trial purpose
Patients that are on total knee/hip replacement initiate prophylaxis treatment on the hospital ground. Once they leave the hospital, as outpatients they continue with the treatment at least during two consecutive weeks. Patients will be instructed to follow treatment recommendations (either LMWH or oral treatment, at physician discretion) and to come back to the surgeon after that period. At that visit, the Treatment Satisfaction Questionaire with Medication (TSQM) test as well as the Moriski-Green Questionaire (measures compliance with medication) will be answer by the patient. TSQM is an self administered validated scale (validated also in spanish) that measures in a generic way the treatment satisfaction to a treatment. Morinski-Green test will be used to measure the compliance degree on medication.
Key Participants Requirements
Sex
BothAge
18 YearsTrial summary
Enrollment Goal
480Trial Dates
November 2008 - March 2009Phase
N/ACould I Receive a placebo
NoProducts
No DrugAccepts Healthy Volunteer
NoWhere to participate
Status | Institution | Location |
---|---|---|
Completed | Many Locations, Spain |
Primary Outcome
- To measure the Treatment Satisfaction with medication through the self administered scale TSQM.date_rangeTime Frame:2 weeksenhanced_encryptionnoSafety Issue:
Secondary Outcome
- To measure compliance with medication and the relationship with satisfaction through the Moriski-Green Questionairedate_rangeTime Frame:2 weeksenhanced_encryptionnoSafety Issue:
Trial design
Trial Type
ObservationalIntervention Type
BehavioralTrial Purpose
N/AAllocation
N/ABlinding
N/AAssignment
N/ATrial Arms
N/A